J Frontier Co.,Ltd.

Tokyo Stock Exchange 2934.T

J Frontier Co.,Ltd. EPS (Diluted) for the year ending May 31, 2024: USD -2.71

J Frontier Co.,Ltd. EPS (Diluted) is USD -2.71 for the year ending May 31, 2024, a 8.09% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • J Frontier Co.,Ltd. EPS (Diluted) for the year ending May 31, 2023 was USD -2.95, a -537.65% change year over year.
  • J Frontier Co.,Ltd. EPS (Diluted) for the year ending May 31, 2022 was USD 0.67, a -20.35% change year over year.
  • J Frontier Co.,Ltd. EPS (Diluted) for the year ending May 31, 2021 was USD 0.85, a 333.75% change year over year.
  • J Frontier Co.,Ltd. EPS (Diluted) for the year ending May 31, 2020 was USD 0.19.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
SV Wall Street
Tokyo Stock Exchange: 2934.T

J Frontier Co.,Ltd.

CEO Mr. Atsuhiro Nakamura
IPO Date Aug. 27, 2021
Location Japan
Headquarters SANWA Aoyama Building
Employees 255
Sector Health Care
Industries
Pharmaceuticals Hospitals & Clinics
Description

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email